This systematic review finds that automated insulin delivery systems enhance glucose control in type 2 diabetes, suggesting their relevance in future management guidelines.
AID systems improved glucose control in a diverse population of individuals with type 2 diabetes requiring insulin therapy with reduction in hypoglycemia. These findings support recommendations for AID systems use in future type 2 diabetes management guidelines.
No takes yet. Share an insight, caveat, or question.
Hespanhol et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: